Aktis Oncology, Inc. (AKTS) P/S ratio

P/S ratio today
131.9×

There is no P/S ratio history on record here for Aktis Oncology, Inc. (AKTS). Aktis Oncology, Inc. (AKTS) trades at 131.9× its revenue per share for fiscal 2025. Figures as of 18 Nov 2026, 09:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; none is on record here for Aktis Oncology, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Aktis Oncology, Inc. P/S ratio, year by year

Aktis Oncology, Inc. (AKTS) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedRevenue per share
Today131.9×——
2025——$0.12
2024——$0.04
2021——$0.15

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on AKTS

Aktis Oncology, Inc., figure by figure

Aktis Oncology, Inc. (AKTS) overview: price, valuation and scorecard

Aktis Oncology, Inc. P/S ratio: questions and answers

What is Aktis Oncology, Inc.'s P/S ratio?

Aktis Oncology, Inc. (AKTS) trades at 131.9× its revenue per share for fiscal 2025.

How is Aktis Oncology, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Aktis Oncology, Inc. (AKTS) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/AKTS/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.